ARCHIVES

Misconduct Finding Is ‘Rare,’ OSI official Tells NCAB

This article is from The Cancer Letter archive.

Vol. 17 No. 24 | June 14, 1991

Download PDF Visit The Full Archive

Related Articles

NCI CTEP: Approved Trials For The Month of October

October 28, 2011

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

Funding opportunties listed.

December 3, 2004

Wendy Will Case Found Invites Applications For Small Grants

April 5, 1991

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999